Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis

Autor: Miha Modic, Jamie S. Mitchell, Jacob Neeves, Jernej Ule, Linda Greensmith, Raphaëlle Luisier, Doaa M Taha, Jia Newcombe, Ione Meyer, Giulia E. Tyzack, Rickie Patani, Nicholas M. Luscombe
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Cytoplasm
amyotrophic lateral sclerosis (ALS)
Induced Pluripotent Stem Cells
Gene Expression
RNA-binding protein
Context (language use)
Mice
Transgenic

Biology
medicine.disease_cause
Biochemistry & Proteomics
intron retention
03 medical and health sciences
Mice
0302 clinical medicine
Ecology
Evolution & Ethology

medicine
Animals
Humans
Amyotrophic lateral sclerosis
Nuclear export signal
Computational & Systems Biology
Cell Nucleus
Mutation
FOS: Clinical medicine
Stem Cells
Amyotrophic Lateral Sclerosis
Intron
Neurosciences
Cell Biology
Tumour Biology
medicine.disease
RNA binding protein
3. Good health
Cell biology
fused in sarcoma FUS
Mice
Inbred C57BL

Cell nucleus
030104 developmental biology
medicine.anatomical_structure
RNA-Binding Protein FUS
Female
Neurology (clinical)
Genetics & Genomics
030217 neurology & neurosurgery
Biomarkers
Reports
Zdroj: Brain
ISSN: 0006-8950
Popis: See Vidal and Atkin (doi:10.1093/brain/awz256) for a scientific commentary on this article. ALS remains incurable due to an incomplete understanding of its molecular pathogenesis. Tyzack, Luisier et al. report that FUS protein, previously thought to mislocalise only in patients with FUS mutations, is also mislocalised in many cases of sporadic ALS. They further propose an underlying molecular mechanism for the mislocalisation.
Mutations causing amyotrophic lateral sclerosis (ALS) clearly implicate ubiquitously expressed and predominantly nuclear RNA binding proteins, which form pathological cytoplasmic inclusions in this context. However, the possibility that wild-type RNA binding proteins mislocalize without necessarily becoming constituents of cytoplasmic inclusions themselves remains relatively unexplored. We hypothesized that nuclear-to-cytoplasmic mislocalization of the RNA binding protein fused in sarcoma (FUS), in an unaggregated state, may occur more widely in ALS than previously recognized. To address this hypothesis, we analysed motor neurons from a human ALS induced-pluripotent stem cell model caused by the VCP mutation. Additionally, we examined mouse transgenic models and post-mortem tissue from human sporadic ALS cases. We report nuclear-to-cytoplasmic mislocalization of FUS in both VCP-mutation related ALS and, crucially, in sporadic ALS spinal cord tissue from multiple cases. Furthermore, we provide evidence that FUS protein binds to an aberrantly retained intron within the SFPQ transcript, which is exported from the nucleus into the cytoplasm. Collectively, these data support a model for ALS pathogenesis whereby aberrant intron retention in SFPQ transcripts contributes to FUS mislocalization through their direct interaction and nuclear export. In summary, we report widespread mislocalization of the FUS protein in ALS and propose a putative underlying mechanism for this process.
Databáze: OpenAIRE